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Abstract
Chemical investigation of a new endophytic fungus, Mycosphaerella sp. nov. strain F2140
associated with the foliage of the plant Psychotria horizontalis (Rubiaceae) in Panama, resulted in
the isolation of cercosporin (1) and a new cercosporin analogue (3) as the major components. The
structures of minor compounds in the extract were elucidated by detailed spectroscopic analysis as
2-(2-butyl)-3-hydroxy-6-ethyl-6-methylcyclohex-2-ene-1,5-dione (4), 3-(2-butyl)-6-ethyl-6-
methyl-5-hydroxy-2-methoxy-cyclohex-2-eneone (5), and an isomer of 5 (6). To study the
influence of the hydroxy groups on the anti-parasitic activity of cercosporin, compound 1 was
acetylated to obtain derivative 2. The isolated compounds 1–6 were tested in vitro to determine
their anti-parasitic activity against the causal agents of malaria (Plasmodium falciparum),
leishmaniasis (Leishmania donovani), and Chagas disease (Trypanosoma cruzi). Also, the
cytotoxicity and potential anticancer activity of these compounds were evaluated using
mammalian Vero cells and MCF7 cancer cell lines, respectively. Compounds 1 and 2 displayed
high potency against L. donovani (IC50 0.46 and 0.64 μM), T. cruzi (IC50 1.08 and 0.78 μM), P.
falciparum (IC50 1.03 and 2.99 μM), and MCF7 cancer cell lines (IC50 4.68 and 3.56 μM).
Compounds 3–6 were not active in these assays at a concentration of 10 μg/mL.
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As part of a continuing program to identify novel compounds for the treatment of parasitic
diseases, the Panamanian International Cooperative Biodiversity Group (ICBG) [1a, 1b] has
been investigating new anti-parasitic agents from plants [1c, 1d], marine organisms [1e, 1f],
and more recently, endophytic fungi [1g, 1h]. In the course of these latter studies, 21 fungal
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strains were isolated from the leaves of a neotropical shrub, Psychotria horizontalis
(Rubiaceae). The extract from a new fungal species, identified as Mycosphaerella sp. nov.,
was selected for further purification based on initial bioactivity results. Herein, we report the
isolation and structural elucidation of a new cercosporin analogue (3) along with cercosporin
(1) as major metabolites, together with four new minor metabolites, 2-(2-butyl)-3-
hydroxy-6-ethyl-6-methylcyclohex-2-ene-1, 5-dione (4), 3-(2-butyl)-6-ethyl-6-methyl-5-
hydroxy-2-methoxy-cyclohex-2-eneone (5), and its isomer 6. The compounds were
evaluated for anti-parasitic and cytotoxic activities. Although cercosporin is a well-known
phytotoxin with significant cytotoxic activity, its potential anti-parasitic activities have not
been previously reported.
Extracts from all the tested growth media were found to be active against T. cruzi (IG, 86–
94%), P. falciparum (IG, 90–99%), and L. donovani (IG, 90.8–99.1%) (Table 1). The
similar, non-selective bioactivity profile of all extracts from F2140 strain led us to the
conclusion that a major compound present in all the extracts likely was responsible for the
activity.
TLC of extracts showed a dark brownish spot corresponding to a molecular weight of 535
amu following analysis by low resolution mass spectrometry. In addition, the MS data of the
mycelial extract from potato dextrose culture showed an additional peak at 537 amu, and
thus was probable an analogue of the major compound. Based on these results, the mycelial
extract of potato dextrose culture was selected for further purification.
Cercosporin (1), the major component of the crude extract, was identified by comparison of
its NMR and MS data with those reported previously [2a, 2b]. Acetylation of cercosporin
gave a tetra-acetate (2; Fig. 1), which showed physicochemical properties consistent with
the literature data [2c, 2d].
The molecular formula of compound 3 was established as C29H28O10 on the basis of its
APCI-HR-MS (m/z 537.1758 [M + H]+). The 1H and 13C NMR signals of 3 were closely
similar to those of 1. However, 3 displayed twice the number of NMR signals, suggesting
the lack of structural symmetry in 3. Also, the NMR signals corresponding to the methylene
group [δH 5.75 (2H, s, H-21); δC 92.6] of the dioxepane ring in compound 1 was replaced
by the signals for a methoxy group [δH 4.27 (3H, s, OMe); δC 57.9] in compound 3,
indicating a ring-opened analogue of cercosporin with a methoxy group at one terminus and
a hydroxy group at the other. The position of the methoxy group in 3 was confirmed by
HMBC correlations from δH 4.27 to δC 163.3 (C-12).
Compound 4 was obtained as colorless oil with a specific rotation ([α] 26D) of −2.6°. The
molecular formula was determined to be C13H20O3 based on the APCI-HR-MS data [M
+H]+ at m/z 225.1471. The 13C spectrum of 4 confirmed the presence of 13 carbon
resonances, with their multiplicities determined from a DEPT spectrum as four methyl [δC
9.2, 12.5, 18.3, and 18.8], three methylene [δC 27.4, 28.1, and 55.9], one methine [δC 33.1]
and five quaternary carbons [δC 50.4, 152.7, 161.6, 207.4, and 209.5]. The HSQC spectrum
identified the corresponding 1H signals for methyl [δH 0.71 (t, J = 7.5 Hz, H-2″), 0.84 (t, J =
7.5 Hz, H-4′), 1.26 (d, J = 7.2 Hz, H-1′), and 1.11 (s, H-1‴)], methylene [δH 1.71 (m,
H-1″), 1.69 (dq, J = 7.5, 15.0 Hz, H-3′), and 4.64 (s, H-4)], and methine [δH 2.85 (m,
H-2′)] groups. Analysis of the COSY spectrum suggested the presence of ethyl and 2-
butanyl moieties. In the HMBC spectrum, H-2′ [δH 2.85] of the sec-butyl group showed
long-range correlations to C-1 [δC 207.4], C-2 [δC 161.6] and C-3 [δC 152.7] indicating that
the 2-butyl group was attached to a double bond (C-2, see Figure 3). HMBC correlations
from the methyl group [δH 1.11] to C-1″ [δC 28.0], C-6 [δC 50.4], C-1 [δC 207.4], and C-5
[δC 209.5] confirmed that the methyl and ethyl groups were attached to C-6. Finally, the
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HMBC correlations of H-4 with C-3, C-2 and C-5 enabled formulation of a six-membered
cyclic diketoenol structure for 4. The absolute configuration of C-6 position was not
determined due to the low amount of compound isolated. Thus, the structure of 4 was
determined to be 2-(2-butyl)-3-hydroxy-6-ethyl-6-methylcyclohex-2-ene-1, 5-dione- (4).
Compound 5 was obtained as colorless oil with a specific rotation ([α] 26D) of +60.2. The
molecular formula was determined as C14H24O3 by APCI-HR-MS in positive ion mode,
displaying a protonated molecular ion peak at m/z 241.1786 [M+H]+. The formula was
consistent with the number of protons and carbons observed in the NMR spectra. In addition
to a methoxy functional group [δH 3.60 (s, OMe), δC 59.9], a methyl [δH 1.14 (s, H-1‴), δC
17.7], an ethyl [δH 0.84 (t, J = 7.5 Hz, H-2″), δC 7.9; δH 1.64 (t, J = 7.5 Hz, H-1″), δC
22.7], and a 2-butyl [δH 1.04 (d, J = 7.0 Hz, H-1′),δC 18.6; δH 3.00 (m, H-2′), δC 34.8; δH
1.41 (m, H-3′), δC 27.1; δH 0.88 (t, J = 7.5 Hz, H-4′), δC 12.5] group were identified from
the NMR data. The remaining six 13C NMR signals [δC 198.0 (C-1), 147.3 (C-2), 146.3
(C-3), 73.1 (C-5), 50.9 (C-6) and 28.8 (C-4)] belonged to a cyclic skeleton similar to 4. The
positions of the functional groups in 5 were confirmed by analysis of HMBC correlations
from methylene [δH 2.48, H-4], methyl [δH 1.14 H-1‴], and methoxy [δH 3.60, OMe]
protons. The sec-butyl group was now attached to C-3 as indicated by the correlation of
H-2′ with C-2 and C-3, and H2-4 with C-2′, C-2, C-3 and C-5. The position of the OMe was
determined by the correlation of this three proton resonance with C-2 (see Figure 2). Thus,
the structure of 5 was determined to be 3-(2-butyl)-6-ethyl-6-methyl-5-hydroxy-2-methoxy-
cyclohex-2-eneone.
Compound 6 was obtained as a colorless oil with a specific rotation ([α] 26D) of +15.7. Its
molecular formula was determined to be C14H24O3 based on the mass spectrum (APCI-HR-
MS) displaying an [M+H]+ at m/z 241.1757. Compound 6 showed very similar NMR
signals to 5 and these were confirmed by further 2D NMR analysis. On the basis of these
data, compound 6 was identified as a diastereomer of 3-(2-butyl)-6-ethyl-6-methyl-5-
hydroxy-2-methoxy-cyclohex-2-eneone
Cercosporin belongs to the perylenequinone-class of metabolites [3] which are of polyketide
origin [4] and are produced by fungi within the genus Cercospora [2b]. It is a
photosensitizing toxin that produces highly reactive superoxide anions as well as singlet
oxygen upon irradiation. This causes peroxidation of membrane fatty acids, leading to
rupture of plasma membrane in plants and cell death [5].
The majority of the thousands of species currently circumscribed as Cercospora lack a
known sexual stage, but in a small number of species a Cercospora anamorph (asexual
stage) has been connected to a Mycosphaerella teleomorph (sexual stage) [6]. Isolate F2140
did not produce sexual or asexual structures in culture, and phylogenetic analyses placed it
in a previously unknown clade of endophytic Mycosphaerella from diverse hosts for which
anamorphs are not presently known [7a, 7b]. Given our observation of cercosporin
production by this isolate we anticipate that F2140 represents a clade of Mycosphaerella
characterized as Cercospora when anamorphic.
Among the extracts from the different growth media, the one obtained from the potato
dextrose culture was found to be the most active in our anti-parasitic assays. Recently,
perylenequinones including cercosporin have been evaluated for toxicity against a broad
spectrum of cancer cell lines and for protein kinase C inhibition activity [8]. However,
previous studies do not appear to describe the activity of cercosporin against parasitic
diseases such as malaria, leishmaniasis and Chagas. The in vitro assay results suggest that
cercosporin is highly active against P. falciparum (IC50 1.03 μM), L. donovani (IC50 0.46
μM), and T. cruzi (IC50 1.08 μM). This bioactivity profile of cercosporin showed that it was
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not selective between the assayed parasites. Except in T. cruzi assay (Table 1), the
acetylated cercosporin showed lower activity compared to the parent compound. However,
the bioactivity of cercosporin varied only slightly when it was acetylated. It is possible that
the hydroxy groups do not have a marked effect on the bioactivity of cercosporin, or that the
esters are labile and removed by esterases upon entering cells. Because the bioassays were
performed in the dark, any possible phototoxic effect of cercosporin on the parasites was
minimized. Compound 1 and 2 showed lower cytotoxicity to mammalian Vero cells (1.54
and 1.24 μM) compared to their anti-leishmanial activity, thus giving a modest therapeutic
window of 3.4 and 1.9, respectively (Table 1). Compound 3, identified as a seven-membered
dioxepane ring-opened analogue of cercosporin, showed a significant reduction in activity in
all of these biological assays (IC50>10 μg/mL), indicating the importance of the
methelenedioxy functionality to the biological properties of compound 1. A similar
reduction activity was also observed with some of the anti-leishmanial alkaloids isolated in
our lab [9]. The minor compounds 4–6 did not show significant activity (IC50>10 μg/mL) in
any of the biological assays.
Overall, the results presented here suggest that cercosporin produced by the new fungal
strain Mycosphaerella sp. nov is responsible for the antiparasitic and cytotoxic activities.
The results also provide further insights into the structure- activity relationship of
cercosporin against the tropical parasites which could be useful in designing more potent
and selective agents against these diseases.
Experimental
Isolation and identification of fungal strain
The host plant P. horizontalis was collected from the tropical forest at Barro Colorado
Natural Monument, Panama and was identified by Dr. Alicia Ibáñez, a voucher specimen
(B1704) was deposited at the Smithsonian Tropical Research Institute, Panama. The fungal
strain was isolated on malt extract agar from a surface-sterilized, healthy, mature leaf in
August 2005 following methods outlined in Arnold and Lutzoni [10]. Because the strain did
not sporulate in culture, phylogenetic analyses of molecular sequence data were used to
verify its taxonomic placement.
Briefly, total genomic DNA was extracted from fresh mycelium following Arnold and
Lutzoni [10]. The nuclear ribosomal internal transcribed spacers and 5.8s gene (nrITS) were
amplified as a single fragment and sequenced bidirectionally at the Genomics and
Technology Core at The University of Arizona using primers ITS1F and ITS4 [11] (for PCR
protocols see Hoffman and Arnold [12] and Higgins et al. [13]). Forward and reverse reads
were assembled and evaluated by phred and phrap [14a,14b] with automation provided by
Mesquite, http://mesquiteproject.org., and manual editing in Sequencher v4.5 (Gene Codes
Corporation, Ann Arbor, MI). The consensus sequence was submitted to a BLAST search of
the NCBI GenBank database for preliminary identification at higher taxonomic levels and to
establish appropriate taxon sampling for phylogenetic analysis. BLAST matches suggested
placement in Mycosphaerella (Mycosphaerellaceae, Capnodiales, Dothideomycetes, and
Ascomycota). To overcome widely recognized limitations associated with BLAST-based
taxonomy, including potential misidentification of sequences, relatively limited
representations of endophytic fungi, and the uncertain validity of taxonomic placement
based on the non-evolutionary BLAST algorithm, were verified placement using
phylogenetic analyses. Briefly, maximum likelihood analyses of two complementary data
sets, the first consisting of 100 sequences of top hits obtained from GenBank, and the second
consisting of 34 sequences of closely related strains and eight strains obtained in broader
surveys of endophyte diversity [7a,7b] confirmed placement in Mycosphaerella and
provided high bootstrap support for recognition of this strain as a novel species relative to
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known diversity in this highly species-rich, and often geographically specialized, genus.
Therefore, the strain was characterized as a new species of Mycosphaerella (Mycosphaerella
sp. nov., Arnold et al. unpub.) [7c]. A voucher specimen was deposited as plugs of agar in
sterile water at the Smithsonian Tropical Research Institute, Panama (accession F2140), and
at the Robert L. Gilbertson Mycological Herbarium, The University of Arizona (accession
F2140/TK1648).
Cultivation and extraction procedures
F2140 was cultured on slants of potato dextrose agar (PDA) at 25°C for 7 days. Agar plugs
(2×2 cm) then were transferred to four different media (700 mL each; malt extract, potato
dextrose, Czapek Dox, and V8) and incubated at 28°C for 15 d on a rotary shaker (120 rpm).
Suspensions from each medium were vacuum-filtered and the filtrate successively
partitioned between hexane, chloroform, and ethyl acetate to obtain 29.6, 32.1, 37.4 mg
(malt extract), 54.4, 129.4, 67.0 mg (potato dextrose), 5.9, 34.7, 28.3 mg (Czapek Dox) and
10.3, 9.4, 8.1 mg (V8) of extract, respectively. Erlenmeyer flasks containing each medium
without inocula were treated in the same way as controls. Mycelial mass collected by
filtration from each medium was homogenized using a polytron and extracted with EtOAc to
produce 149.7, 1511.5, 226.1, and 81.1 mg of extract from each medium, respectively. A
total of 16 extracts, obtained as described above, were evaluated for their anti- parasitic
activity at a concentration of 10 μg/mL.
Isolation of compounds
Mycelial extract from potato dextrose (100 mg from 1.5 g) was chromatographed on a
GRACE Econosphere NP-HPLC column (250 × 10 mm) using CHCl3-MeOH (97:3) as
eluents for 40 min at a flow rate of 1.5 mL/min to yield two major compounds: cercosporin
(1) (47 mg, tR 17.2 min), and a new isomer of cercosporin (3) (20 mg, tR 21.3 min).
Following Kuyama et al. [2c], 10 mg of cercosporin was acetylated in pyridine using acetic
anhydride to obtain a tetra-acetyl derivative. The remainder of the extract (1.4 g) was
fractionated over a silica column (70–230 mesh, Merck) using hexanes- CHCl3, CHCl3-
MeOH mixtures and MeOH as eluents to give three subfractions (A-C). Subfraction A (20
mg) was further purified on an Xterra C18 HPLC column (250 × 10 mm) using 35%
aqueous MeCN for 60 min at a flow rate of 1.5 mL/min to obtain a mixture (5.6 mg, tR 44.6
min) and the new compound (4) (2.0 mg, tR 46.7min). The mixture of compounds was
successfully separated using a normal phase HPLC column chromatography (GRACE
Econosphere, 250 × 10 mm) using an isocratic solvent system containing hexanes-CHCl3
(4:6) for 30 min at a flow rate of 1.0 mL/min to give two new compounds (5) (2.0 mg, tR
46.7min), and (6) (0.9 mg, tR 52.5 min), respectively.
General experimental procedures
Optical rotations were measured with a Rudolf Research Analytical Autopol III 6971
automatic polarimeter. NMR spectra were recorded on a Bruker spectrometer with standard
pulse sequences operating at 300 MHz in 1H NMR and 75 MHz in 13C NMR using TMS as
an internal chemical shift reference. Mass spectra were acquired on a JEOL LC-mate mass
spectrometer. TLC was performed on precoated silica gel plates (Kieselgel 60, F254, 20 ×
20 cm, 0.25 mm thick, Merck). Spots were detected by staining with a solution of p-
anisaldehyde-sulfuric acid in methanol followed by heating. Reverse phase HPLC was
performed on a Waters 600 model system with a photodiode array UV detector 2996.
Normal phase HPLC was performed on a Waters 1515 model system with a dual
wavelength UV detector model 2487.
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Bioassays
Leishmania bioassay
Axenically grown (cell free) amastigotes of L. donovani (LD-1S/MHOM/SD/00-strain 1S),
the species responsible for the visceral and lethal forms of leishmaniasis, were used to assess
parasite growth and survival. Samples were tested in duplicate at 10 μg/mL. The results
were expressed as a percentage of growth inhibition (IG) compared to controls. Samples that
showed above 70% IG were considered active and were then assayed at four different
concentrations (0.08, 0.4, 2, and 10 μg/mL) to determine IC50 values. Amphotericin B was
used as a positive control with the typical IC50 response of 0.08–0.13 μM [1h,15].
Chagas’ disease bioassays
T. cruzi bioassays were performed using a colorimetric method, and the inhibition of
parasite growth was assessed by the expression of the reporter gene for beta-galactosidase
(β-Gal) in the recombinant Tulahuen clone C4 of T. cruzi. Assays were performed in
duplicate on the amastigote, the intracellular form of the parasite infecting African green
monkey kidney (Vero) cells, exposed during 120 h to different concentrations (10, 2 and 0.4
μg/mL) of the test compounds at 37°C under an atmosphere of 5% CO2/95% air. The
resulting color from the cleavage of chlorophenol red-β-D-galactoside (CPRG) by β-Gal
expressed by the parasite was measured at 570 nm. The concentration that inhibited 50%
expression of β-Gal (IC50) was calculated by log regression of the obtained optical density
values, and compared with the untreated controls. Nifurtimox was used as a positive control
(IC50 10–16 μM) [16,17].
Malaria bioassays
Antiplasmodial activity was evaluated using a fluorometric method based on the detection of
parasite DNA with the fluorochrome PicoGreen using a chloroquine-resistant strain
(Indochina W2) of P. falciparum. The sample was considered active if it inhibited >70% of
the growth of the parasites as compared to their untreated controls at 10 μg/ml. The IC50
was calculated by normal regression of the resulting inhibition percentages at 0.08, 0.4, 2,
and 10 μg/mL. The parasites were maintained in vitro by a modification of the method of
Trager and Jensen [18a]. Chloroquine was used as a positive control (IC50 80–100 nM) [1g,
18b].
Cancer bioassays
Cytotoxic activity against MCF-7 human breast cancer cells was performed following the
standard protocol of the National Cancer Institute [19]. Adriamycin was used as a positive
control (IC50 0.02–0.3 nM).
Mammalian Cell Cytotoxicity bioassay
Vero cells, derived from kidneys of the African green monkey, were adhered to 96-well
plates and examined for reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT, Sigma-Aldrich, St. Louis, MO). After treatment with the test compound for
4 h of incubation at 37°C, cell viability was evaluated in an ELISA reader at 570 nm [1g,17,
and 20].
Compound 3
Dark red powder.
[α]D26: −879 (c 0.045, CHCl3).
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1HNMR (300 MHz, CDCl3): δ 0.61 (d, J = 6.2 Hz, 3H, H-3′), 0.65 (d, J = 6.2 Hz, 3H,
H-3″), 2.79 (dd, J = 12.7, 6.0 Hz, 1H, H-1a″), 2.85 (dd, J = 12.7, 6.0 Hz, 1H, H-1a′), 3.40
(m, 1H, H-2″), 3.43 (m, 1H, H-2′), 3.51 (dd, J = 12.7, 1.9 Hz, 1H, H-1b″), 3.53 (dd, J =
12.7, 2.7 Hz, 1H, H-1b′), 4.19 (s, 3H, H-23), 4.20 (s, 3H, H-22), 4.27 (s, 3H, H-21), 6.86 (s,
1H, H-13), 6.91 (s, 1H, H-3).
13CNMR (75 MHz, CDCl3): δ 23.6 (C-3″), 23.8 (C-3′), 42.2 (C-1″), 42.4 (C-1′), 58.1
(C-21), 61.6 (C-22, C-23), 68.5 (C-2′, C-2″), 101.9 (C-3), 106.3 (C-10), 107.1 (C-20),
107.9 (C-13), 112.7 (C-1), 113.5 (C-11), 128.2 (C-9), 129.5 (C-19), 131.6 (C-17/7), 134.5
(C-8), 136.2 (C-18), 152.9 (C-6), 153.2 (C-16), 161.5 (C-12), 163.3 (C-2), 169.5 (C-4),
170.0 (C-14), 180.5 (C-5), 181.8 (C-15). APCI-HR-MS m/z 537.1758 [M+H]+ (calcd for
C29H29O10, 537.1761).
2-(2-butyl)-6-ethyl-3-hydroxy-6-methylcyclohex-2-ene- 1, 5-dione (4)—Colorless
oil.
[α]D26: −2.6 (c 0.07, CHCl3).
1HNMR (300 MHz, CDCl3): δ 0.71 (t, J = 7.4 Hz, 3H, H-2″), 0.84 (t, J = 7.4 Hz, 3H,
H-4′), 1.11 (s, 3H, H-1‴), 1.26 (d, J = 7.1 Hz, 3H, H-1′), 1.69 (m, 2H, H-1″), 1.71 (m, 2H,
H-3′), 2.85 (m, 1H, H-2′), 4.64 (s, 2H, H-4).
13CNMR (75 MHz, CDCl3): δ 9.2 (C-2″), 12.5 (C-4′), 18.3 (C-1′), 18.8 (C-1‴), 27.4
(C-3′), 28.1 (C-1″), 33.1 (C-2′), 50.4 (C-6), 55.9 (C-4), 152.7 (C-3), 161.6 (C-2), 207.4
(C-1), 209.5 (C-5).
APCI-HR-MS m/z 225.1471 [M+H]+ (calcd for C13H21O3, 225.1491);
3-(2-butyl)-6-ethyl-5-hydroxy-2-methoxy-6-methyl-cyclohex-2-enone (5)—
Colorless oil.
[α]D26: +60.2 (c 0.04, CHCl3).
1HNMR (300 MHz, CDCl3): δ 0.84 (t, J = 7.7 Hz, 3H, H-2″), 0.88 (t, J = 7.4 Hz, 3H,
H-4′), 1.04 (d, J = 7 Hz, 3H, H-1′), 1.14 (s, 3H, H-1‴), 1.41 (m, 2H, H-3′), 1.64 (m, 2H,
H-1″), 2.39 (dd, J = 18.1, 8.2 Hz, 1H, H-4a), 2.56 (dd, J = 18.1, 5.2 Hz, 1H, H-4b), 3.00 (m,
1H, H-2′), 3.60 (s, 3H, OMe), 3.88 (t, J = 8.2, 5.2 Hz, 1H, H-5) 13CNMR (75 MHz,
CDCl3): δ 7.9 (C-2″), 12.5 (C-4′), 17.7 (C-1‴), 18.6 (C-1′), 22.7 (C-1″), 27.1 (C-3′), 28.8
(C-4), 34.8 (C-2′), 50.9 (C-6), 59.9 (OMe), 73.1 (C-5), 146.3 (C-3), 147.3 (C-2), 198.0
(C-1).
APCI-HR-MS m/z 241.1786 [M+H]+ (calcd for C14H25O3, 241.1804);
Compound 6
Colorless oil.
[α]D26: +15.7 (c 0.07, CHCl3).
1HNMR (300 MHz, CDCl3): δ 0.84 (t, J = 7.3 Hz, 3H, H-2″), 0.85 (t, J = 7.3 Hz, 3H,
H-4′), 1.05 (d, J = 7.0 Hz, 3H, H-1′), 1.14 (s, 3H, H-1‴), 1.41 (m, 2H, H-3′), 1.65 (m, 2H,
H-1″), 2.35 (dd, J = 18.2, 7.6 Hz, 1H, H-4a), 2.45 (dd, J = 18.2, 5.1 Hz, 1H, H-4b), 3.01 (m,
1H, H-2′), 3.60 (s, 3H, OMe), 3.89 (t, J = 5.4 Hz, 1H, H-5). 13CNMR (75 MHz, CDCl3): δ
6.8 (C-2″), 11.3 (C-4′), 16.9 (C-1‴), 17.3 (C-1′), 21.7 (C-1′), 26.4 (C-3′), 27.9 (C-4), 33.6
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(C-2′), 49.6 (C-6), 58.9 (OMe), 71.9 (C-5), 144.9 (C-3), 146.2 (C-2), 197.1 (C-1). APCI -
HR-MS m/z 241.1757 [M+H]+ 241.1804).
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Figure 1.
Chemical Structures of the Isolated Metabolites (1, 3–5) and one Derivative (2).
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Figure 2.
Key HMBC correlations for placing substituents on compounds 4 and 5
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